BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37328533)

  • 1. HIV status and survival of patients with pulmonary hypertension due to left heart disease: the Pan African Pulmonary Hypertension Cohort.
    Katoto PDMC; Mukasa SL; Sani MU; Karaye KM; Mbanze I; Damasceno A; Mocumbi AO; Dzudie A; Sliwa K; Thienemann F
    Sci Rep; 2023 Jun; 13(1):9790. PubMed ID: 37328533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary hypertension as seen in a rural area in sub-Saharan Africa: high prevalence, late clinical presentation and a high short-term mortality rate during follow up.
    Dzudie A; Dzekem BS; Tchoumi CT; Aminde LN; Mocumbi AO; Abanda M; Thienemann F; Kengne AP; Sliwa K
    Cardiovasc J Afr; 2018 Jul/Aug 23; 29(4):208-212. PubMed ID: 30059129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The causes, treatment, and outcome of pulmonary hypertension in Africa: Insights from the Pan African Pulmonary Hypertension Cohort (PAPUCO) Registry.
    Thienemann F; Dzudie A; Mocumbi AO; Blauwet L; Sani MU; Karaye KM; Ogah OS; Mbanze I; Mbakwem A; Udo P; Tibazarwa K; Damasceno A; Keates AK; Stewart S; Sliwa K
    Int J Cardiol; 2016 Oct; 221():205-11. PubMed ID: 27404676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Factors for Survival in Pulmonary Hypertension Due to Left Heart Disease.
    Yamabe S; Dohi Y; Fujisaki S; Higashi A; Kinoshita H; Sada Y; Hidaka T; Kurisu S; Yamamoto H; Kihara Y
    Circ J; 2016; 80(1):243-9. PubMed ID: 26581623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary Hypertension in Heart Failure. Epidemiology, Right Ventricular Function, and Survival.
    Gerges M; Gerges C; Pistritto AM; Lang MB; Trip P; Jakowitsch J; Binder T; Lang IM
    Am J Respir Crit Care Med; 2015 Nov; 192(10):1234-46. PubMed ID: 26181215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary hypertension predicts all-cause mortality in patients with heart failure: a retrospective cohort study.
    Szwejkowski BR; Elder DH; Shearer F; Jack D; Choy AM; Pringle SD; Struthers AD; George J; Lang CC
    Eur J Heart Fail; 2012 Feb; 14(2):162-7. PubMed ID: 22178623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Follow-up of Human Immunodeficiency Virus-Associated Pulmonary Hypertension: Clinical Features and Survival Outcomes of the Pan Africa Pulmonary Hypertension Cohort (PAPUCO).
    Thienemann F; Katoto PDMC; Azibani F; Kodogo V; Mukasa SL; Sani MU; Karaye KM; Mbanze I; Mocumbi AO; Dzudie A; Sliwa K
    Open Forum Infect Dis; 2022 Dec; 9(12):ofac604. PubMed ID: 36601555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Circulating MicroRNA-206 Level Predicts the Severity of Pulmonary Hypertension in Patients with Left Heart Diseases.
    Jin P; Gu W; Lai Y; Zheng W; Zhou Q; Wu X
    Cell Physiol Biochem; 2017; 41(6):2150-2160. PubMed ID: 28554172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of warfarin on survival in patients with concomitant left ventricular systolic dysfunction and pulmonary hypertension: a population cohort study.
    Goudie A; Elder D; Deshmukh H; Szwejkowski BR; Lang CC; George J
    Eur J Heart Fail; 2015 Jan; 17(1):90-7. PubMed ID: 25427720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary hypertension due to left heart disease: The prognostic implications of diastolic pulmonary vascular pressure gradient.
    Ibe T; Wada H; Sakakura K; Ikeda N; Yamada Y; Sugawara Y; Mitsuhashi T; Ako J; Fujita H; Momomura S
    J Cardiol; 2016 Jun; 67(6):555-9. PubMed ID: 26299611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphodiesterase 5 inhibitors for pulmonary hypertension.
    Barnes H; Brown Z; Burns A; Williams T
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD012621. PubMed ID: 30701543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale and design of the Pan African Pulmonary hypertension Cohort (PAPUCO) study: implementing a contemporary registry on pulmonary hypertension in Africa.
    Thienemann F; Dzudie A; Mocumbi AO; Blauwet L; Sani MU; Karaye KM; Ogah OS; Mbanze I; Mbakwem A; Udo P; Tibazarwa K; Ibrahim AS; Burton R; Damasceno A; Stewart S; Sliwa K
    BMJ Open; 2014 Oct; 4(10):e005950. PubMed ID: 25763797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and therapeutical follow-up of HIV-associated pulmonary hypertension: prospective study of 10 patients.
    Recusani F; Di Matteo A; Gambarin F; D'Armini A; Klersy C; Campana C
    AIDS; 2003 Apr; 17 Suppl 1():S88-95. PubMed ID: 12870536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peak oxygen uptake is a strong prognostic predictor for pulmonary hypertension due to left heart disease.
    Zhong XJ; Jiang R; Yang L; Yuan P; Gong SG; Zhao QH; Luo CJ; Qiu HL; Li HT; Zhang R; He J; Wang L; Tang J; Liu JM
    BMC Cardiovasc Disord; 2022 Mar; 22(1):137. PubMed ID: 35361128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and outcomes of pulmonary hypertension in the cardiac intensive care unit.
    Jentzer JC; Wiley BM; Reddy YNV; Barnett C; Borlaug BA; Solomon MA
    Eur Heart J Acute Cardiovasc Care; 2022 Mar; 11(3):230-241. PubMed ID: 35064269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics and Prognostic Associations of Echocardiographic Pulmonary Hypertension With Normal Left Ventricular Systolic Function in Patients ≥90 Years of Age.
    Shimada S; Uno G; Omori T; Rader F; Siegel RJ; Shiota T
    Am J Cardiol; 2020 Aug; 129():95-101. PubMed ID: 32624190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of left ventricular ejection fraction on heart failure patients with pulmonary hypertension.
    Zafrir B; Carasso S; Goland S; Zilberman L; Klempfner R; Shlomo N; Radzishevsky E; Hasin T; Shotan A; Vazan A; Weinstein JM; Kinany W; Dragu R; Maor E; Grosman-Rimon L; Amir O
    Heart Lung; 2019; 48(6):502-506. PubMed ID: 31174892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical myectomy improves pulmonary hypertension in obstructive hypertrophic cardiomyopathy.
    Geske JB; Konecny T; Ommen SR; Nishimura RA; Sorajja P; Schaff HV; Ackerman MJ; Gersh BJ
    Eur Heart J; 2014 Aug; 35(30):2032-9. PubMed ID: 24334721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined pre- and post-capillary pulmonary hypertension: The clinical implications for patients with heart failure.
    Ibe T; Wada H; Sakakura K; Ugata Y; Maki H; Yamamoto K; Seguchi M; Taniguchi Y; Jinnouchi H; Momomura SI; Fujita H
    PLoS One; 2021; 16(3):e0247987. PubMed ID: 33651852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary Arterial Capacitance Predicts Cardiac Events in Pulmonary Hypertension Due to Left Heart Disease.
    Sugimoto K; Yoshihisa A; Nakazato K; Jin Y; Suzuki S; Yokokawa T; Misaka T; Yamaki T; Kunii H; Suzuki H; Saitoh SI; Takeishi Y
    PLoS One; 2016; 11(11):e0165603. PubMed ID: 27875533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.